Categories
Topics

EPFL scientists have found that stiffening the membranes of cancer cells can lead to improved immunotherapy outcomes. Preclinical tests show that it can increase long-term survival rates to nearly 50%.

EPFL scientists have found that stiffening the membranes of cancer cells can lead to improved immunotherapy outcomes. Preclinical tests show that it can increase long-term survival rates to nearly 50%. Laboratory of Biomaterials for Immunoengineering. Li Tang, Kewen Lei, and Armand Kurum

Media properties

Themes
Research and Tech Transfer , Cancer, STI, Research and Tech Transfer
Copyright
© Alain Herzog / EPFL
Licence
CC0 Licence
Shooting date
Dec. 7, 2021
Album
Rigidifying cancer cells for better immunotherapy

Share on